Media stories about Analogic (NASDAQ:ALOG) have trended somewhat positive on Monday, Accern reports. The research group identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Analogic earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave news articles about the medical research company an impact score of 47.2978649077282 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news articles that may have impacted Accern Sentiment’s analysis:
- Analogic (ALOG) Upgraded at Zacks Investment Research (americanbankingnews.com)
- Jefferies Group Weighs in on Analogic Co.’s Q3 2018 Earnings (ALOG) (americanbankingnews.com)
- Analogic (ALOG) Q2 2018 Earnings Conference Call Transcript (finance.yahoo.com)
- WINTON GROUP Ltd Takes $5.69 Million Position in Analogic Co. (ALOG) (americanbankingnews.com)
- Analogic (ALOG) Issues Quarterly Earnings Results (americanbankingnews.com)
Several research firms recently issued reports on ALOG. Zacks Investment Research upgraded shares of Analogic from a “hold” rating to a “strong-buy” rating and set a $108.00 price target on the stock in a research report on Thursday. BidaskClub lowered shares of Analogic from a “sell” rating to a “strong sell” rating in a research report on Saturday, January 6th. Finally, Jefferies Group reiterated a “hold” rating and set a $80.00 price target on shares of Analogic in a research report on Friday, December 8th.
Analogic (NASDAQ:ALOG) last issued its earnings results on Monday, March 5th. The medical research company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.58. Analogic had a negative net margin of 15.34% and a positive return on equity of 6.05%. The firm had revenue of $129.20 million for the quarter, compared to analyst estimates of $112.50 million. During the same quarter last year, the business posted $0.99 earnings per share. The company’s quarterly revenue was down 1.7% on a year-over-year basis. equities research analysts expect that Analogic will post 4.23 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Thursday, March 15th will be given a $0.10 dividend. The ex-dividend date is Wednesday, March 14th. This represents a $0.40 dividend on an annualized basis and a yield of 0.42%. Analogic’s dividend payout ratio is currently -6.91%.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.